BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31023444)

  • 1. How Low Do We Go (in the Post-SPRINT Era)?
    Burgner A; Lewis JB
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):110-116. PubMed ID: 31023444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure Goals in Patients with CKD: A Review of Evidence and Guidelines.
    Chang AR; Lóser M; Malhotra R; Appel LJ
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):161-169. PubMed ID: 30455322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of SPRINT study from the point of nephrology].
    Monhart V
    Vnitr Lek; 2016; 62 Suppl 6():55-57. PubMed ID: 28124932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of blood pressure in chronic kidney disease: how low to go?
    Faqah A; Jafar TH
    Nephron Clin Pract; 2011; 119(4):c324-31; discussion c331-2. PubMed ID: 22135791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The African American Study of Kidney Disease: do these results indicate that 140/90 mm hg is good enough?
    Rahman M; El-Meanawy A; Romanello J
    Curr Hypertens Rep; 2005 Oct; 7(5):363-6. PubMed ID: 16157080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Tyson CC; Coffman TM
    Nephron; 2017; 135(4):287-290. PubMed ID: 28161697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease.
    Ruzicka M; Burns KD; Hiremath S
    Can J Cardiol; 2017 May; 33(5):611-618. PubMed ID: 28365055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort.
    Nakajima A; Tanaka K; Saito H; Iwasaki T; Oda A; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2020 May; 24(5):427-434. PubMed ID: 31875937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Managing hypertension in patients with chronic kidney disease - implications of the SPRINT study].
    Wojtaszek E; Głogowski T
    Wiad Lek; 2016; 69(5):742-744. PubMed ID: 28033599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.
    Chertow GM; Beddhu S; Lewis JB; Toto RD; Cheung AK
    J Am Soc Nephrol; 2016 Jan; 27(1):40-3. PubMed ID: 26553785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPRINT and the Kidney: What Have We Learned?
    Wells R; Rahman M
    Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and kidney disease: what do the data really show?
    Cohen DL; Townsend RR
    Curr Hypertens Rep; 2012 Oct; 14(5):462-7. PubMed ID: 22814743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Representation of Real-World Adults With Chronic Kidney Disease in Clinical Trials Supporting Blood Pressure Treatment Targets.
    Li J; An J; Huang M; Zhou M; Montez-Rath ME; Niu F; Sim JJ; Pao AC; Charu V; Odden MC; Kurella Tamura M
    J Am Heart Assoc; 2024 Apr; 13(7):e031742. PubMed ID: 38533947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension Management in Chronic Kidney Disease and Diabetes: Lessons from the Systolic Blood Pressure Intervention Trial.
    Thomas G
    Cardiol Clin; 2019 Aug; 37(3):307-317. PubMed ID: 31279424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learned from the current trials?
    Abbott KC; Bakris GL
    Med Clin North Am; 2004 Jan; 88(1):189-207. PubMed ID: 14871059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines.
    Roehm B; Weiner DE
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):245-250. PubMed ID: 30762614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies.
    Gosmanova EO; Kovesdy CP
    Curr Cardiol Rep; 2016 Sep; 18(9):88. PubMed ID: 27448402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.